IL-5 and -6 expression levels in the AD + AA-L (15% and 16%, respectively) and AD + AA-H (2% and 5%, respectively) groups were increased compared with those in the CON group; however, there was no significant difference. This evidence concerns the gene IL5 and Alzheimer disease.